Home
About
Overview
Sharing Data
ORCID
Help
History (16)
Assortative mating enhances postzygotic barriers to gene flow via ancestry bundling.
Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.
Bayesian estimation of gene constraint from an evolutionary model with gene features.
Herd Immunity: Understanding COVID-19.
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia.
Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia. EBioMedicine. 2015 Apr; 2(4):284.
View in:
PubMed
subject areas
Adrenergic beta-2 Receptor Agonists
Cholesterol, LDL
Dyslipidemias
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Targeted Therapy
authors with profiles
Michael Davidson